Effect of Plavix on Limb Salvage Following Endovascular Lower Extremity Revascularization  by Janzen, Mark L. et al.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 5 Abstracts 1435Objectives: Readmission following vascular surgery intervention is
frequent, costly, and often considered preventable. Vascular surgery
outcomes have recently been scrutinized by Medicare, given high rates of
readmission. We determine patient and clinical characteristics that predict
readmission in a cohort of vascular surgery patients.
Methods: From 2009 to 2013, the medical records of all patients
(n ¼ 2505) undergoing interventions by the vascular surgery service at
a single tertiary care institution were retrospectively reviewed. Sociodemo-
graphic and clinical characteristics were examined for association with 30-
day readmission.
Results: The 30-day readmission rate to the same institution was
9.7% (n ¼ 244). Procedures most likely to result in readmission were
below-knee (25%), foot (22%), and toe amputations (19%), as well as
lower extremity revisions (22%). Patients covered by Medicaid
(16.8%) and Medicare (10.0%) were most likely to be readmitted fol-
lowed by fee-for-service (9.5%), self-pay (8.0%), and health maintenance
organization (5.5%; P < .05). Patients urgently admitted were more
likely to be readmitted (16.2%) than electively admitted patients
(9.1%; P < .01). Patient severity (rated using 3M APR DRG software)
predicted readmission (16.2% high vs 6.2% low severity; P < .01). Initial
length of stay was longer for readmitted than nonreadmitted patients
(8.5 vs 6.1 days, respectively; P < .01). Intensive care unit admission
during initial hospitalization was moderately associated with higher
readmission rates (18.3% with vs 9.5% without intensive care unit
stay; P < .05). Discharge destination was also a strong predictor of
readmission (rehabilitation, 19.2%; skilled nursing facility, 16.2% vs
home, 6.2%; P < .01). The effects of urgent admission, illness severity,
length of stay, and discharge destination persisted in multivariable
logistic regression.
Conclusions: To reduce readmission rates effectively, institutions
must identify high-risk patients. Efforts should focus on subgroups under-
going selected interventions (amputations, vascular revisions), as well as
urgent admissions and those with extended hospital stays. Patients in
need of postacute care upon discharge are especially prone to readmission,
requiring special attention to discharge planning and coordination of post-
discharge care.
Combined Carotid Endarterectomy and Coronary Artery Bypass
Grafting: Which Is Better, Simultaneous or Staged Approach?
Mustafa Baldawi, Stephen Stanek, Weikai Qu, Hammad Amer, Jihad Abbas,
Munier Nazzal. Department of Surgery, University of Toledo Medical
Center, Toledo, Ohio
Objectives: To compare the morbidities, mortality, length of stay,
and total cost between simultaneous and staged carotid endarterectomy
(CEA) and coronary artery bypass grafting (CABG).
Methods: Utilizing the Nationwide Inpatient Sample (NIS), we
studied all the patients that underwent CEA and CABG between 2008
and 2010. International Classiﬁcation of Disease, Ninth Revision codes
were used to look for procedure types, comorbidities, and complications.
Data analysis was done using SPSS v.19 (IBM, Armonk, NY); statistical
signiﬁcance was deﬁned as P < .05.
Results: Both CEA and CABG (CEA/CABG) was done in 8568
patients. CEA/CABG group was categorized into Simultaneous CEA/
CABG (SmCC; same day; 4534 [52.9%]), and Staged CEA/CABG
(StCC; different days, same admission; 2209 [25.8%]); 1825 (21.3%)Table. Adjusted and nonadjusted comparison of simultaneous and staged carot
Nonadjusted
Simultaneous Staged P
No. 4534 2209
LOS, days (median) 9 13 <.01
Total cost, USD (median) 124,544 171,094 <.01
Mortality 181/4% 98/4% .390
Myocardial infarction 1099/24% 558/25% .366
Stroke 90/2% 49/2% .528
LOS, Length of stay.
aStandardized coefﬁcient.patients were excluded (deﬁcient coding). When SmCC was compared
with StCC, Length of stay (LOS) and total charges were signiﬁcantly
higher in StCC; however, no signiﬁcant difference was found in
mortality, in-hospital myocardial infarction, or postoperative stroke.
After adjustment for comorbidities (hypertension, diabetes mellitus,
congestive heart failure, smoking and peripheral vascular disease),
comparison of SmCC and StCC yielded comparable results for LOS
and total charges, but no signiﬁcant differences in mortality, in-hospital
myocardial infarction, and postoperative stroke between SmCC and
StCC (Table).
Conclusions: In patients with combined CEA/CABG, simultaneous
surgery carries lower charges, LOS, mortality and stroke rate as compared
with staged procedures in the same admission.
Effect of Plavix on Limb Salvage Following Endovascular Lower
Extremity Revascularization
Mark L. Janzen, Viktor Y. Dombrovskiy, Edgar L. Galiñanes, Todd R.
Vogel. University of Missouri Hospitals and Clinics, Columbia, Mo
Objectives: This study evaluated amputation-free-survival in patients
identiﬁed utilizing Plavix (Clopidogrel) following their lower extremity
endovascular revascularization (LER).
Methods: Patients 65 years of age and greater undergoing LER were
identiﬁed from MedPAR ﬁles (2007 to 2008) utilizing International Classi-
ﬁcation of Disease, Ninth Revision codes. Demographics, comorbidities,
and severity of disease (claudication, rest pain, ulceration/gangrene
[UG]) are evaluated. Postprocedural use of Plavix was identiﬁed using the
National Drug Code directory and Part D ﬁles. Outcomes were measured
using c2 analysis, multivariable logistic regression, Kaplan-Meier, and Cox
regression.
Results: A total of 14,353 patients were identiﬁed: 7189 with clau-
dication (50.1%), 1467 with rest pain (10.2%), 5697 with UG (39.7%).
Of these, 5416 (37.7%) patients were identiﬁed using Plavix after LER.
Overall, patients initiated on Plavix had lower amputation rates at 30
days (10.34% vs 14.09%; P < .0001), 90 days (14.05% vs 18.71%; P
< .0001), and 1 year (19.68% vs 24.06%; P < .0001). Multivariate
logistic regression analysis adjusted by age, gender, race, and comorbid-
ities conﬁrmed that non-Plavix users were more likely to undergo ampu-
tation at 30 days (odds ratio [OR], 1.28; 95% conﬁdence interval [CI],
1.14-1.43), 90 days (OR, 1.29; 95% CI, 1.16-1.43), and 1 year (OR,
1.16; 95% CI, 1.05-1.28). Males, blacks, congestive heart failure, dia-
betes, and renal failure were signiﬁcant predictors of amputation. In
c2, logistic regression, and Cox regression analyses, Plavix did not signif-
icantly affect amputation rates in patients with claudication or rest pain.
Patients with UG who did not receive Plavix were signiﬁcantly more
likely to undergo amputation at 30 days (OR, 1.29; 95% CI, 1.14-
1.45), 90 days (OR, 1.28; 95% CI, 1.15-1.43), and 365 days (OR,
1.19; 95% CI, 1.07-1.31).
Conclusions: Utilization of Plavix after LE endovascular revasculari-
zation was associated with lower rates of amputation, yet only 38% of the
Medicare population was identiﬁed as using Plavix after intervention.
Patients with UG beneﬁted the greatest with signiﬁcantly greater amputa-
tion-free survival and overall survival. Prospective randomized trials are
needed to assess the suggested beneﬁts of Plavix on amputation-free survival
after LE endovascular revascularization.id endarterectomy (CEA) and coronary artery bypass grafting (CABG)
Adjusted
Odds ratio P 95% conﬁdence interval
0.182a <.01 3.178 3.965
0.070a <.01 14641 24291
0.943 .671 0.720 1.236
0.994 .924 0.880 1.123
0.878 .478 0.613 1.258
Fig.
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in Peripheral Arterial Disease Patients
Panagiotis Koutakis, Dustin J. Weiss, Aikaterini A. Nella, Stanley A.
Swanson, Zhen Zhu, Dimitrios Miserlis, Evlampia Papoutsi, Jason M.
Johanning, Iraklis I. Pipinos, George P. Casale. Department of Surgery,
University of Nebraska Medical Center, Omaha, Neb; Yale University of
Medicine, New Haven, Conn; and the National Institute of Child Health
and Human Development, Bethesda, Md
Objectives: Peripheral arterial disease (PAD) affects approximately
8.5 million Americans and is characterized by the formation of athero-
sclerotic plaques in the arteries limiting the blood supply in the legs.
Previous studies have demonstrated that oxidative damage (carbonyl
and 4-hydroxyl-2-nonenal adducts) in PAD muscle ﬁbers is higher
than control gastrocnemius and correlates with disease progression. In
this study, we investigated the effect of oxidative damage in myoﬁber
type (slow and fast twitch) of gastrocnemius muscle while the disease
is progressing.
Methods: Muscle biopsies were collected with a Bergstrom needle
from PAD-claudication patients (PAD-C; n ¼ 28), PAD-critical limb
ischemia patients (PAD-CLI; n ¼ 25), and control subjects (n ¼ 25). Quan-
titative ﬂuorescence microscopy was used to label the myoﬁber sarco-
lemmas, carbonyl adducts, and the slow/fast/hybrid twitch ﬁbers.
Differences between and within the groups of carbonyl adducts and myo-
ﬁber cross-sectional area of each myoﬁber type were measured. A discrimi-
nant model was used to categorize muscle specimens on the basis of the
disease progression.
Results: Carbonyl adducts in gastrocnemius ﬁbers were higher in
PAD-C and PAD-CLI patients when compared with control ﬁbers for all
myoﬁber types. Cross-sectional area of fast twitch and hybrid ﬁbers was
signiﬁcantly decreased when compared with control ﬁbers (P < .05). Fast
twitch and hybrid ﬁbers demonstrated a signiﬁcant increase of oxidative
damage (P < .01) when compared with slow twitch ﬁbers for both the
PAD-C and PAD-CLI groups. Fast twitch ﬁbers frequency was decreased
while the disease was progressing, while slow and hybrid twitch ﬁbers
frequency was increased. The discriminant model demonstrated that
ankle-branchial index, oxidative damage, and cross-sectional area of fast
twitch ﬁbers can accurately identify controls (100% accuracy), PAD-C
(78.6% accuracy), and PAD-CLI (84% accuracy) with an overall classiﬁca-
tion accuracy of 87.2%.
Conclusions: Oxidative damage is myoﬁber-type-sensitive towards
fast twitch and hybrid ﬁbers. The discriminant model establishes that fast
twitch ﬁbers are more susceptible to degeneration in association with
increased oxidative damage.Liposuction-Assisted Brachio-cephalic Fistula in the Morbidly Obese:
Functional Patency and Reimbursement
William McMillan, Chantel Hile. Department of Vascular Surgery,
Minneapolis Vascular Physicians, Plymouth, Minn
Objectives: Arterio-venous ﬁstulas (AVFs) are preferred for hemodial-
ysis, but upper arm brachio-cephalic ﬁstula (BCF) in the obese patient is
problematic with poor functional patency. Technical reports demonstrate
the feasibility of liposuction to facilitate cannulation, but no long-term func-
tional patency data are available. There is also no published information
regarding liposuction reimbursement for this indication. We report func-
tional patency and reimbursement for BCF with staged liposuction in obese
dialysis patients.
Methods: Retrospective analysis of primary and secondary functional
patency in 30 consecutive obese patients (19 female, 28 diabetic; body mass
index, 40.03) undergoing both BCF placement and staged liposuction at
a single center. All patients underwent preoperative venous mapping and
had the ﬁstula placed under local anesthesia. All patients had a duplex ultra-
sound at 14 days (prior to liposuction) and at 30-days postplacement. Patients
were followed weekly, and all secondary interventions were recorded. Profes-
sional and technical revenues for the liposuction procedurewere also recorded.
Results: Immediate technical success was achieved in all 30 patients.
Four additional patients had BCF placement but never had liposuction
due to poor or occluded outﬂow vein on preliposuction duplex. No patient
had a postoperative infection or hematoma, and all ﬁstulas were patent by
ultrasound at 1 month. Twenty-eight of 30 ﬁstulas achieved functional
patency with a mean time to initial cannulation post-liposuction of 20
days (range, 12-42 days). Primary functional patency for the 30 liposuction
patients was 93.25% at 12 months (standard error <10%) with mean follow-
up of 17.7 months (range, 0-42 months). Mean professional reimbursement
was $1295, and technical reimbursement (to the ASC) was $1745.
Conclusions: Brachiocephalic ﬁstula placement with staged liposuc-
tion is an effective strategy for hemodialysis access in the obese patient
with respectable functional patency rates. Reimbursement is favorable for
both the surgeon and the facility. Randomized studies comparing upper
arm AVF with liposuction to forearm grafts are needed to determine the
optimal strategy for hemodialysis access in obese patients.
Single-Center Thirty-Two-Year Experience in the Treatment of
Ruptured Abdominal Aortic Aneurysms
Audra A. Duncan, Mateus P. Correa, Manju Kalra, W. Scott Harmsen,
Andrew M. Bakken, Gustavo Oderich, Mark D. Fleming, Peter Gloviczki,
Thomas C. Bower. Mayo Clinic, Rochester, Minn
